Unknown

Dataset Information

0

Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro.

ABSTRACT: In addition to its essential role in viral polyprotein processing, the SARS-CoV-2 3C-like (3CLpro) protease can cleave human immune signaling proteins, like NF-κB Essential Modulator (NEMO) and deregulate the host immune response. Here, in vitro assays show that SARS-CoV-2 3CLpro cleaves NEMO with fine-tuned efficiency. Analysis of the 2.14 Å resolution crystal structure of 3CLpro C145S bound to NEMO 226-235 reveals subsites that tolerate a range of viral and host substrates through main chain hydrogen bonds while also enforcing specificity using side chain hydrogen bonds and hydrophobic contacts. Machine learning- and physics-based computational methods predict that variation in key binding residues of 3CLpro- NEMO helps explain the high fitness of SARS-CoV-2 in humans. We posit that cleavage of NEMO is an important piece of information to be accounted for in the pathology of COVID-19.

SUBMITTER: Hameedi MA 

PROVIDER: S-EPMC8609902 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

In addition to its essential role in viral polyprotein processing, the SARS-CoV-2 3C-like (3CLpro) protease can cleave human immune signaling proteins, like NF-κB Essential Modulator (NEMO) and deregulate the host immune response. Here, <i>in vitro</i> assays show that SARS-CoV-2 3CLpro cleaves NEMO with fine-tuned efficiency. Analysis of the 2.14 Å resolution crystal structure of 3CLpro C145S bound to NEMO <sub>226-235</sub> reveals subsites that tolerate a range of viral and host substrates th  ...[more]

Similar Datasets

Unknown Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro.
| S-EPMC9453703 | biostudies-literature
Unknown SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis.
| S-EPMC8958254 | biostudies-literature
Unknown Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors.
| S-EPMC2112940 | biostudies-other
Unknown Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds.
| S-EPMC9015912 | biostudies-literature
Unknown Coronavirus 3CLpro proteinase cleavage sites: possible relevance to SARS virus pathology.
| S-EPMC442122 | biostudies-literature
Unknown Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro.
| S-EPMC7470085 | biostudies-literature
Unknown Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs.
| S-EPMC7127318 | biostudies-literature
Unknown Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.
| S-EPMC7395220 | biostudies-literature
Unknown Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells.
| S-EPMC8078197 | biostudies-literature
Unknown Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease.
| S-EPMC10116374 | biostudies-literature